Article
Myelopoietic efficacy of orlistat in murine hosts bearing T cell lymphoma: implication in macrophage differentiation and activation.
PloS one - 1 Jan 2013
Kant Shiva, Kumar Ajay, Singh Sukh Mahendra
Abstract excerpt
Orlistat, an inhibitor of fatty acid synthase (FASN), acts as an antitumor agent by blocking de novo fatty acid synthesis of tumor cells. Although, myelopoiesis also depends on de novo fatty acid synthesis, the effect of orlistat on differentiation of macrophages, which play a central role in host's antitumor defence, remains unexplored in a tumor-bearing host. Therefore, the present investigation was undertaken...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
